Cite
HARVARD Citation
Owonikoko, T. et al. (n.d.). A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG–ACRIN Cancer Research Group (E2511). Lung cancer. 89 (1), pp. 66-70. [Online].